Procyon Life Sciences Pvt Ltd

Country/Region: India     State/Province: New Delhi

Main Products: Oxyclozanide, Oxyclozanide

Company Introduction
Procyon Life Sciences ( API & Intermediates ) Greetings From India. Procyon Life Sciences ( Procyon ) is a medium sized pharmaceutical API Company based in Mumbai, the Commercial Capital of India. Engaged in Manufacturing & Exports of selected Pharmaceutical Bulk actives (Human & Veterinary) to customers worldwide. Procyon has made sizable inroads in European, South American and Asian markets. Procyon has, to its credit, long term supply arrangements with reputed clients. Procyon has the required Technical , Regulatory and Synthesis capabilities suitable for high volume as well as Low Volume production . Over the years we have grown on the strength of our service and its mission to provide quality goods with value. Today we have diversified into several product lines and categories , offering from Staring Raw materials to Finished products. ï?? Bulk Drug Intermediates ( As Per Customer requirement ) ï?? Selected Range APIâ??s ï?? Formulations ï?? Custom Synthesis / Contract Manufacturing ï?? Nutraceuticals. We understand that your Company is one of the major users / importers of Bulk Actives. Procyon offers the Bulk Actives as per the enclosed list. Kindly let us know your interest / requirement so as enable us to send you our specifications and best quote. We sincerely hope to initiate discussions with you at the earliest to associate with you on a long-term basis and look forward to your reply. With Best Regards, Business Development Executive .</p>
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2005, 2005

Legal Status: Third Party

Ownership: Private Limited

Employees: 101 - 200 People

Factory Size: 1, 000-3, 000 square meters

R&D Team Size: 11 - 50 People

Certifications: TL9000

Contact Information

Contact Person: Rajveer

Designation: Board Chairman/CEO

Department: Prop

Telephone: 91919821270098

Business Information

Main Markets: Canada (27%) Australia (27%) France (27%) United Kingdom (24%) South Korea (21%)

Export Focus: Australia, Canada, France, South Korea, United Kingdom

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx 0.5 Billion US Dollar

Registered Capital: US$5 Million - US$10 Million

Export Percentage: 21% - 30%

Payment Terms: Bank wire (T/T)

Product Showcase
Oxyclozanide
Oxyclozanide

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Health Care Supplement in India Health Care Supplement in New Delhi Oxyclozanide in India Oxyclozanide in New Delhi